Anti-tumor effect of intratumoral administration of induced pluripotent stem cell-derived NKT cells on glioblastoma through CD155/DNAM-1 interaction
Ko Ozaki(Chiba University), Shinichiro Motohashi(Chiba University), Masayoshi Kobayashi(Chiba University), Kai Nishii(Chiba University), Kiyoshi Hirahara(Chiba University), Mariko Takami(Chiba University), Daiki Shimizu(Kyoto Pharmaceutical University), Yoshinori Higuchi(Chiba University), Hidekazu Tanaka(Chiba University), Keita Ogawa(Chiba University), Takahiro Aoki(Saitama Children's Medical Center), Kiwamu Motoyoshi, Midori Kobayashi(FIND), Iori Kojima(Chiba University), Motoko Y. Kimura(Chiba University), Haruhiko Koseki(RIKEN Center for Integrative Medical Sciences), Toshihiro Ito(Chiba University), Katsuhiro Nishimura(Chiba University), Daisuke Katsumi(Chiba University), Hongxuan Wang(Chiba University)
Cited by 3
Related Papers
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
|PLoS Genetics|2008|1k
Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
|Cell stem cell|2013|412
Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication
|Nature|2013|409
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
|Cancer Immunology Research|2015|332